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Abstract: Anthrax lethal toxin (LeTx) and edema toxin (EdTx) have been shown to alter 
hemodynamics in the rodent model, while LeTx primarily is reported to induce extensive 
tissue pathology. However, the rodent model has limitations when used for comparison to 
higher  organisms  such  as  humans.  The  rabbit  model,  on  the  other  hand,  has  gained 
recognition as a useful model for studying anthrax infection and its  pathophysiological 
effects. In this study, we assessed the hemodynamic effects of lethal toxin (LeTx) and 
edema toxin (EdTx) in the rabbit model using physiologically relevant amounts of the 
toxins. Moreover, we further examine the pathological effects of LeTx on cardiac tissue. 
We  intravenously  injected  Dutch-belted  rabbits  with  either  low-dose  and  high-dose 
recombinant  LeTx  or  a  single  dose  of  EdTx.  The  animals’  heart  rate  and  mean  
arterial  pressure  were  continuously  monitored  via  telemetry  until  either  48  or  72  h  
post-challenge. Additional animals challenged with LeTx were used for cardiac troponin I 
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(cTnI) quantitation, cardiac histopathology, and echocardiography. LeTx depressed heart 
rate at the lower dose and mean arterial pressure (MAP) at the higher dose. EdTx, on the 
other hand, temporarily intensified heart rate while lowering MAP. Both doses of LeTx 
caused  cardiac  pathology  with  the  higher  dose  having  a  more  profound  effect.  Lastly,  
left-ventricular dilation due to LeTx was not apparent at the given time-points. Our study 
demonstrates the hemodynamic effects of anthrax toxins, as well as the pathological effects 
of LeTx on the heart in the rabbit model, and it provides further evidence for the toxins’ direct 
impact on the heart. 
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1. Introduction 
Bacillus anthracis, the causative agent of anthrax, brings about extensive pathophysiology during 
the course of human infection, and it is associated with an extremely high mortality rate if either no 
treatment is administered or treatment is delayed [1–4]. The bacteria secrete three proteins known as 
protective antigen (PA), lethal factor (LF), and edema factor (EF). These proteins combine to form two 
exotoxins,  lethal  toxin  (LeTx;  PA  and  LF)  and  edema  toxin  (EdTx;  PA  and  EF)  [5].  LF  is  a  
zinc-metalloprotease that cleaves all but one mitogen activated protein kinase kinase (MAPKK) [6–8], 
while  EF  is  a  high  rate  calmodulin-dependent  adenylate  cyclase  that  produces  an  abundance  of 
intracellular  cAMP  [6,8,9].  Upon  binding  to  target  receptors  on  host  cells,  monomers  of  PA,  the 
receptor-binding moiety, heptamerize and bind three units of LF and/or EF. The entire complex then 
undergoes endocytosis, forming an endosome that later acidifies and releases the units of LF and EF 
into the cytosol [8,10,11]. Here, LF and EF is capable of altering cellular physiology and/or inducing 
cell death [11–13]. 
Past reports have highlighted the contributions of LeTx and EdTx to the overall pathophysiology 
associated with anthrax infection [14–20], with some elucidating the cardiovascular effects [21–23]. 
The toxins have been shown to bring about distinct hemodynamic outcomes that are believed to be 
partially  responsible  for  the  sequelae  associated  with  inhalational  anthrax  infection,  namely 
hemodynamic instability and shock [21,23]. Interestingly, the incidence of cardiovascular instability 
has led some investigators to further examine the pathological and physiological effects of the toxins 
on the heart [22]. Despite the novelty of these studies, nearly all of them were limited to the use of the 
rodent model which has limitations when used for comparison to higher organisms, namely humans. 
The rabbit model, on the other hand, has gained recognition as a reliable animal model for studying 
inhalational anthrax infection, primarily due to the similar anthrax-related pathology/pathophysiology 
between rabbits and humans [24]. 
In  this  study  we  assess  the  hemodynamic  effects,  including  heart  rate  (HR)  and  mean  arterial 
pressure (MAP), of LeTx and EdTx in the rabbit model using physiologically relevant amounts of the 
toxins. Furthermore, we examine the degree of cardiac tissue pathology caused by LeTx which is the 
exotoxin historically known to bring about significant tissue destruction. We accomplish this by using 
telemetry  (while  the  animals  were  fully  conscious  and  unrestrained),  echocardiography, Toxins 2011, 3                                       
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histopathology,  and  blood  analysis.  To  our  knowledge,  this  is  the  first  report  describing  the 
hemodynamic and cardiac effects of recombinant anthrax toxins in the rabbit model. 
2. Materials and Methods 
2.1. Animals 
Specific-pathogen-free female Dutch-belted dwarf rabbits (Myrtle’s Rabbitry, Thompson Station, 
TN) were studied at  approximately 14 weeks  of age, weighing 1.5 to  2.0 kg. Upon delivery,  the 
animals were singly housed at the University of Texas Medical Branch Animal Resources Center or 
the Galveston National Laboratory in stainless steel, ventilated rabbit racks (Allentown, Allentown, 
NJ)  and  allowed  to  acclimate  for  a  minimum  of  one  week  before  the  commencement  of  any 
experimental procedures. Rabbits were fed approximately 170 g of 5321 rabbit diet (PMI LabDiet, 
Richmond, IN) daily and given water  ad libitum. The animal room was maintained on a 12:12 h 
light:dark cycle, with the temperature range at 19 to 22 ° C and the humidity between 30% and 70%. 
Animal procedures were conducted under protocols approved by the University of Texas Medical 
Branch Institutional Animal Care and Use Committee. 
2.2. Telemetry Instrumentation and Data Acquisition 
The telemetry equipment was purchased from Data Sciences International in St. Paul, MN. The 
implantable  transmitter  (model  TL11M3-D70-PCTP)  had  two  pressure  leads  for  monitoring  mean 
arterial pressure (MAP) and two biopotential leads for recording electrocardiogram (ECG). The system 
also included the Data Exchange Matrix and the RMC-1 wireless receiver. The software used for data 
analysis was Dataquest A.R.T. gold 4.1. 
Aseptic  surgical  implantation  of  the  transmitters  (model  TL11M3-D70-PCTP)  (Data  Sciences 
International, St. Paul, MN) was accomplished as previously described [24]. Briefly, the animals were 
anesthetized  with  ketamine  (10–15  mg/kg  IM)  (Fort  Dodge  Animal  Health,  Fort  Dodge,  IA)  and 
diazepam (0.3–0.5 mg/kg IM) (Hospira, Inc., Lake Forest, Ill), and maintenance was achieved with the 
use of 2–4% isoflurane (Webster Veterinary, Sterling, MA). A midline laparotomy was made at the 
middle 1/3 of the abdomen, while a second incision was made on the medial aspect of the left thigh. 
The  femoral  artery  was  isolated  and  cannulated  with  one  of  the  two  pressure  catheters  on  the 
transmitter (the other pressure catheter was not used). Lastly, the catheter was tied down with stay 
sutures, and the animal’s incision was closed in routine fashion. The electrocardiogram (ECG) leads 
were exteriorized from the abdomen just cranial to the laparotomy incision. A skin incision was made 
on the cranial aspect of the right hemi-thorax, and a subcutaneous tunnel was made just cranial to the 
midline incision to the above mentioned incision site for placement of the negative lead. The positive 
lead was placed just cranial to the last rib. Both ECG leads was sutured into the muscle layer. The 
animals were allowed to recover 1 to 2 weeks before subsequent procedures. 
Heart rate (HR), mean arterial pressure (MAP), and ECG were recorded continuously (every 60 s) 
for 24 h before challenge and for either 48 or 72 h thereafter. The recorded data for HR and MAP were 
used to compute a two-hour moving average. These data were in turn exported to an Excel spreadsheet 
for graph preparation. ECG was recorded continuously as 1 min segments. Toxins 2011, 3                                       
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2.3. Challenge Procedure 
LeTx-challenged  animals  received  recombinant  LF  and PA  (BEI Resources,  Manassas, VA) at 
doses of either 0.67 mg/kg and 0.24 mg/kg (low-dose) or 0.98 mg/kg and 1.95 mg/kg (high-dose), 
respectively. EdTx-challenged animals received recombinant EF and PA at a dose of 0.13 mg/kg and 
0.24 mg/kg, respectively. The control animals received only the vehicle (PBS). Administration of the 
toxins or PBS, which occurred following a 24 h control period, was accomplished by intravenous 
injection into the animals’ marginal ear veins. 
2.4. Measurement of Cardiac Troponin I 
Blood was collected from the animals’ ears (central artery) before and after LeTx-challenge. The 
times of collection after challenge were 24, 48, and 72 h. Immediately following collection, the whole 
blood  was  analyzed  using  an  iSTAT-1  handheld  clinical  analyzer  (Abbott  Point  of  Care,  Inc., 
Princeton, NJ). 
2.5. Histological Analysis 
The rabbits were anesthetized and the hearts were excised 72 h post-challenge. The hearts were 
sectioned in a coronal plane and washed in PBS. Following, the tissue sections were perfused with 
10% phosphate buffered formalin. Tissue sections were routinely processed, embedded in paraffin, 
sectioned at 5 µm, and stained with hematoxylin and eosin (H&E) and evaluated by light microscopy. 
Tissue lesions were scored based on a severity scale of minimal, mild, moderate, and marked; the scale 
correlated with estimates of lesion distribution and extent of tissue involvement (i.e., minimal = 2–10%; 
mild > 10–20%; moderate > 20–50%; severe > 50). Acute inflammation indicated the presence of 
polymorphonuclear leukocytes (heterophils). 
2.6. Echocardiography 
Echocardiography was performed using a Sonosite Titan ultrasound (Sonosite, Bothell, WA) with 
an  8-MHz  probe.  The  animals  were  anesthetized  with  2–4%  isoflurane.  Echocardiography  was 
performed 24 h prior to injection of high-dose LeTx and at 1, 2, 4, 24, and 48 h post-challenge.  
M-mode analysis from the right parasternal short-axis view was used to determine the left ventricular 
internal diameter during systole (LVIDs) and diastole (LVIDd). 
2.7. Statistical Analysis 
Data were evaluated for statistical significance using analysis of variance and linear regression 
procedures.  Power  was  checked  at  each  test.  For  the  cTnI  study,  linear  regression  analyses  were 
conducted  to  assess  the  significance  of  the  observed  time-related  change.  Both  parametric  and  
non-parametric analyses were performed, and the inferences were the same. For the echocardiography 
study,  overall  group  means  were  compared  using  the  inter-animal  variation  as  the  error  variance. 
However, the pooled animal by time interaction mean square was used as the error variance to assess 
the significance of overall time-related means differences and for comparing group means at individual Toxins 2011, 3                                       
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time periods. For the telemetry data, the timewise comparisons among the groups were made using 
Student t-tests with p < 0.05 as the significance level. Statistical calculations were made using NCSS 
(Kaysville, Utah). 
3. Results 
3.1. Changes in Heart Rate and Mean Arterial Pressure 
The  average  HR  of  the  animals  given  low-dose  LeTx  began  to  fall  several  hours  after  toxin 
administration (Figure 1A). By 50 h, which was 26 h post-challenge, the average HR of the challenged 
animals  was  significantly  lower  than  the  control  group,  and  it  remained  notably  lower  for  the 
remainder of the recording period. With regards to the ECG, there were no apparent abnormalities 
(data not shown). Due to the association between heart rate and blood pressure, we also recorded the 
corresponding  MAP  of  which  there  were  no  changes  in  either  the  control  group  or  the  low-dose  
LeTx-challenged group (Figure 1B). 
Conversely, administration of high-dose LeTx did not bring about any significant difference in the 
average HR of the challenged animals relative to the control group (Figure 2A). It does, however, 
appear that the average HR begins to decline hours after challenge, but it rebounds at approximately 35 h 
and reaches its peak by 72 h after which the recording was stopped and the animals were euthanized. 
Also, there were no apparent changes in the ECG (data not shown). The corresponding average MAP 
of the animals given high-dose LeTx fell dramatically following challenge and was significantly lower 
than the control animals at the end of the recording period (Figure 2B). The recording period for the 
high-dose  animals  was  shorter  than  that  of  the  low-dose  animals  due  to  the  fact  that  by  
48  h  post-challenge,  a  couple  of  the  high-dose  animals  appeared  moribund  and  were  therefore  
humanely euthanized. 
EdTx induced a tachycardic response immediately after challenge with the average HR reaching 
nearly 320 bpm (Figure 3A). Even though this peak HR was not statistically different from the control 
group, it was, however, far above the HR of the challenged animals during their 24 h control period. 
By approximately 16 h post-challenge (40 h), the average HR of the EdTx-challenged animals returned 
to or below control levels. The ECG recordings revealed no changes (data not shown). There was also 
a decline in the corresponding average MAP that did not rebound during the recording period (Figure 3B). 
By 14 h post-challenge, the MAP of the challenged animals was significantly lower than that of the 
control animals. Toxins 2011, 3                                       
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Figure 1. The effects of low-dose LeTx on (A) HR and (B) MAP. Rabbits (n = 3 per 
group) were intravenously injected with 0.67 mg/kg LF and 0.24 mg/kg PA following a  
24 h control period. The parameters were recorded continuously, and the data are presented 
as  a  two-hour  moving  average.  The  red  arrow  denotes  the  time  of  challenge,  and  the 
vertical bars represent two standard errors of the means. * Indicates different from the 
corresponding control time-point (p < 0.05). 
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Figure 2. The effects of high-dose LeTx on (A) HR and (B) MAP. Rabbits (n = 3 per group) 
were intravenously injected with 0.98 mg/kg LF and 1.95 mg/kg PA following a 24 h 
control period. The parameters were recorded continuously, and the data are presented as a 
two-hour moving average. The red arrow denotes the time of challenge, and the vertical 
bars  represent  two  standard  errors  of  the  means.  *  Indicates  different  from  the 
corresponding control time-point (p < 0.05). 
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Figure 3. The effects of EdTx on (A) HR and (B) MAP. Rabbits (n = 3 per group) were 
intravenously injected with 0.13 mg/kg EF and 0.24 mg/kg PA following a 24 h control 
period.  The  parameters  were  recorded  continuously,  and  the  data  are  presented  as  a  
two-hour moving average. The red arrow denotes the time of challenge, and the vertical 
bars  represent  two  standard  errors  of  the  means.  *  Indicates  different  from  the 
corresponding control time-point (p < 0.05). 
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3.2. Cardiac Pathology 
Animals that were challenged with low-dose LeTx showed a steady, significant (p < 0.05) increase 
in the amount of cTnI detected in the blood over time, although there was a large variation at the latest 
time-point (Figure 4). By 48 h post-challenge, the cTnI level rose nearly 50% (0.19 ±  0.08 ng/mL), and 
by 72 h post-challenge, the level rose over 100% (0.45 ±  0.26 ng/mL). Histopathological analysis 
revealed the presence of mild myodegeneration/necrosis and subacute inflammation with histiocytes, 
mononuclear cells, and heterophils present (Figure 5). 
Figure 4. Average cTnI level in blood of rabbits challenged with low-dose LeTx. Rabbits 
(n = 5) were intravenously injected with  0.67  mg/kg  LF and 0.24 mg/kg PA, and the 
concentration  of  cTnI  in  the  blood  was  measured  each  day  for  3  days  after  challenge  
(0 h was before challenge). The vertical bars represent two standard errors of the means. 
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Figure  5.  Cardiac  histopathology  of  rabbit  challenged  with  low-dose  LeTx  versus  
control rabbits. Challenged rabbits were intravenously administered 0.67 mg/kg LF and  
0.24  mg/kg  PA.  The  hearts  were  collected  72  h  post-challenge  and  fixed  in  10%  
buffered formalin. The tissues were then processed, embedded in paraffin, sectioned and  
analyzed  by  light  microscopy.  The  arrows  indicate  areas  of  necrosis.  (A)  Control;  
(B) Low-Dose LeTx. 
 
(A)          (B) 
In the case of high-dose challenged rabbits, there was a dramatic increase in the levels of cTnI, with 
the largest increase occurring by 48 h post-challenge (Figure 6). Important to note is that some animals 
had cTnI values greater than the measurable range (50 ng/mL) at 48 and 72 h post-challenge, and that Toxins 2011, 3                                       
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blood was not collected from all the animals at 72 h post-challenge because two of the five animals 
had to be euthanized before the collection time. There was acute, multifocal cardiac muscle/myocyte 
necrosis with and without mineralization in the ventricles and the interventricular septum which was 
moderate  in  severity  (Figure  7).  In  the  second  histopathology  panel,  the  arrows  indicate  areas  of 
necrosis with prominent mineralization. Moreover, acute inflammation (heterophils) in the heart was 
consistent in all the animals challenged with high-dose LeTx. 
Figure 6. Average cTnI level in blood of rabbits challenged with high-dose LeTx. Rabbits 
(n = 5) were intravenously injected with  0.98  mg/kg  LF and 1.95 mg/kg PA, and the 
concentration  of  cTnI  in  the  blood  was  measured  each  day  for  3  days  after  challenge  
(0 h was before challenge). ‡ Indicates that one or more values were above the maximum 
test range (50 ng/mL). ∆ indicates that n = 3 at this time-point. The vertical bars represent 
two standard errors of the means. 
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Figure  7.  Cardiac  histopathology  of  rabbit  challenged  with  high-dose  LeTx  versus  
control rabbits. Challenged rabbits were intravenously administered 0.98 mg/kg LF and  
1.95 mg/kg PA. The hearts were collected 72 h post-challenge and fixed in 10% formalin. 
The tissues were then processed, embedded in paraffin, sectioned and analyzed by light 
microscopy. The arrows indicate areas of necrosis. (A) Control; (B) High-Dose LeTx 
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3.3. Echocardiography 
The internal diameter of the left ventricular cavity was measured by M-mode echocardiography in 
order to ascertain the presence of ventricular dilation following challenge with high-dose LeTx. Both 
the  systolic  and  diastolic  diameters  for  the  high-dose  LeTx-challenged  animals  did  not  change 
significantly (Figure 8A,B). The same analysis was performed on a separate group of animals at 48 h 
post-challenge which corresponds to the time at which the level of cTnI was highest, however, there 
was no increase in the internal diameter (data not shown). 
Figure  8.  Echocardiography  in  rabbits  challenged  with  high-dose  LeTx.  Rabbits  were 
intravenously administered 0.98 mg/kg LF and 1.95 mg/kg PA. The left ventricular internal 
diameter during systole (LVIDs) (A) and diastole (LVIDd) (B) was measured at 1, 2, 4, 
and 24 h post-challenge. The vertical bars represent two standard errors of the means. 
(A) 
4.00
4.50
5.00
5.50
6.00
6.50
7.00
7.50
0 1 2 4 24
Time (h)
L
V
I
D
s
 
(
m
m
)
control
HD LeTx
 
(B) 
9.00
9.50
10.00
10.50
11.00
11.50
12.00
0 1 2 4 24
Time (h)
L
V
I
D
d
 
(
m
m
)
control
HD LeTx
 Toxins 2011, 3                                       
 
 
732 
4. Discussion 
The amounts of toxin we chose to administer corresponds to the quantities of LeTx and EdTx 
measured in the sera of rabbits that were either soon to expire or had recently expired from infection 
initiated by challenge with virulent anthrax spores [25,26]. Our low-dose LeTx and EdTx were derived 
from  Molin  et  al.  [26],  and  our  high-dose  LeTx  was  derived  from  Mabry  et  al.  [25]  (our  PA 
concentration in the high dose was lower than what was reported). In using these physiologically 
relevant amounts of toxin, we hoped to bring about the physiological effects that one would expect to 
see in the late stages of anthrax infection in the rabbit model. Also important to note is that our  
low-dose LeTx and EdTx were non-lethal doses, while the high-dose LeTx caused approximately 40% 
of the animals to become moribund (moribund animals were euthanized). 
The low-dose LeTx was able to depress HR in the rabbit model without altering MAP, however, the 
decline did not progress past a certain level, possibly due to our use of a single injection. Interestingly, 
this waning HR was also reported in  rats [16,22] that were administered LeTx either by a single 
injection or by continuous infusion. Administration of high-dose LeTx, on the other hand, caused no 
sustainable  decrease  in  the  average  HR,  but  it  did  induce  severe  hypotension  which  progressed 
continually following challenge. This depression in MAP could be due to the ability of LeTx to destroy 
endothelial cells, thereby producing a compromised vasculature  [12], as well as to its  capacity to 
cleave intact MAPKKs that contribute to normal smooth muscle contraction [27,28]. With regards to 
HR, we suspect that there was no bradycardic response after high-dose LeTx-challenge because of the 
feedback mechanism known as reflex tachycardia whereby the heart will beat faster in order to raise 
blood pressure. In examining the data closely, it appears that the average HR begins to  fall after  
high-dose LeTx-challenge, but upon decline of the average MAP, the HR rebounds. Furthermore, the 
average  HR  steadily  increases  until  the  end  of  the  recording  period  which  corresponds  with  the 
progressively declining MAP. This feedback mechanism may have also occurred in canines that were 
infused with high-dose LeTx [29]. Similar to our rabbit model, the canines showed an elevated HR 
concomitant with  a depressed MAP following  LeTx-challenge. Overall, our findings  in  the rabbit 
model, along with those reported previously in rodents [16,22], support the idea that LeTx directly 
alters cardiac physiology by acting as a negative chronotropic agent, and because so, could directly 
influence the sinoatrial (SA) node which acts as the pacemaker for the heart. The absence of any 
arrhythmias,  which  would  be  apparent  by  ECG,  further  suggests  that  the  physiological  effect  is 
restricted primarily to the SA node and not at the myocardial tissue. Further evidence for the direct 
effect of LeTx on the heart was recently reported in an isolated perfused rat heart model [30]. Here, the 
investigators demonstrated that a high dose of LeTx can depress HR in an isolated heart as well. 
Nonetheless, with regards to an in vivo model, the toxin could also depress HR by inducing changes in 
the nervous system (i.e., parasympathetic stimulation). Unfortunately, the precise role of MAPKKs, 
the target of LeTx, in cardiac contraction is not completely known. 
The hemodynamic effects of EdTx that we present here in the rabbit model parallel those reported 
in both the rodent model [22] and canine model [29]. Moreover, in the isolated rat heart model, there is 
also  a transient  increase in  HR  [30]. The  changes are due to  the toxin’s ability to produce large 
amounts of intracellular cAMP. This second messenger increases heart rate by indirectly stimulating Toxins 2011, 3                                       
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Ca
2+ release from the sarcoplasmic reticulum [31], and it lowers blood pressure by relaxing smooth 
muscles that line the vasculature [32]. 
Due to the cytotoxicity of LeTx in various organs of rodents [17,19], we sought to determine the 
pathological  effects  of  the  toxin  on  cardiac  tissue  which  would  in  turn  alter  hemodynamics.  The 
pathology we observed in the cardiac tissue of the low-dose LeTx-challenged animals was mild, yet 
notable, and marked by cardiomyocyte necrosis and inflammation. The same was seen in the high-dose 
LeTx-challenged rabbits but to a greater extent. The incidence of mineralization, which is evidence of 
the necrotic process, and the cTnI levels distinguished the effects of the low-dose and high-dose LeTx. 
Unfortunately,  much  of  the  pathology  observed,  especially  with  the  high-dose  LeTx-challenged 
animals, could be due to tissue hypoperfusion which would result from the severe hypotension, but the 
fact that even the low-dose LeTx-challenged animals showed a significant increase in cTnI over time 
with  normal  MAP  discounts  this.  Instead,  it  suggests  that  the  toxin  can  damage  cardiac  tissue  
much like other organ tissues. After all, past reports show that MAPK ERK 1/2 inhibition promotes  
stress-induced apoptosis and heart failure [33]. 
Despite what has been reported previously in rodents after LeTx challenge [19,22], we did not 
observe left ventricular systolic/diastolic dilation in the rabbits following challenge with  high-dose 
LeTx. For the animals that we used in this analysis, we administered only the higher dose of LeTx due 
to the possibility that any change in myocardial structure, as in the case of ventricular dilation, might 
not occur as readily as a functional change (such as with HR), and therefore would require more toxin. 
However, there still was no significant change with the higher dose. This discrepancy in ventricular 
dilation between our rabbit model and the rodent model can possibly be attributed to the amount of 
toxin administered. Rabbits might require much more LeTx (to achieve a higher mortality) to show the 
cardiac dilation similar to that of rodents. Then again, in looking at the doses of LeTx on a per-kg 
basis, our rabbits received more toxin than the rodents involved in previous studies, with our high dose 
being much more. If we were to challenge our rabbits with similar doses (on a per kg basis) as the 
rodents in past reports, we possibly would have had 0% morbidity. This implies that, when comparing 
different animal models, body size alone is not sufficient for determining the quantity of toxin that 
would propagate notable pathophysiology. 
5. Conclusions 
In this report, we present certain hemodynamic effects of anthrax toxins in the rabbit model. Similar 
studies have been performed in the past, however, they primarily employed the rodent model which at 
times has inadequacies as a model system, especially when used to make generalizations about higher 
organisms. We find that LeTx and EdTx can in fact alter hemodynamics in rabbits similar to that of 
rodents, however, our results suggest that in the case of LeTx, there is a difference with regards to the 
level of susceptibility between the two models as based on the amount of LeTx administered on a per kg 
basis. Another difference that we observed was the absence of ventricular dilation in our rabbit model. 
We hope these findings add to what is known about anthrax pathophysiology in animal models. Toxins 2011, 3                                       
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